RIEFLIN WILLIAM JL — SEC insider filings
SEC reporting owner CIK 1182471. 20 insider filings on record with FilingPulse; latest filed 2026-10-26.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2020-11-20 to 2026-10-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $162,200 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: purchase of 10,000 shares @ $16.22 ($162,200) in RAPT Therapeutics, Inc., filed 2020-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. (RAPT) | Director | 8 | 1 leg · 10,000 sh · $162,200 | — | 7 |
| NGM BIOPHARMACEUTICALS INC (NGM) | Director | 4 | — | — | 11 |
| Lyell Immunopharma, Inc. (LYEL) | Director | 6 | — | — | 6 |
| Lycia Therapeutics, Inc. (LYCA) | Director | 2 | — | — | 2 |
Insider filings — RIEFLIN WILLIAM JL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-26 | 4 | Lycia Therapeutics, Inc. (LYCA) | Grant/award (A): 24,840 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-10-22 | 3 | Lycia Therapeutics, Inc. (LYCA) | Holdings only — no transactions reported | EDGAR |
| 2026-06-12 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 9,250 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 36,490 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) | Code (U): 5,172 · Code (U): 2,769,168 · Disposition to issuer (D): 78,407 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · +2 more | EDGAR |
| 2024-04-01 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 11,871 (derivative) @ $7.58 | EDGAR |
| 2023-09-08 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 12,940 (derivative) @ $0 | EDGAR |
| 2023-05-12 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) | Grant/award (A): 78,407 (derivative) @ $0 | EDGAR |
| 2023-04-10 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 6,026 (derivative) @ $14.52 | EDGAR |
| 2022-06-10 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2022-05-26 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 8,500 (derivative) @ $0 | EDGAR |
| 2022-04-04 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 5,207 (derivative) @ $16.80 | EDGAR |
| 2022-03-04 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2021-06-24 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2021-03-18 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2020-11-20 | 4 | RAPT Therapeutics, Inc. (RAPT) | Purchase (P): 10,000 @ $16.22 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1182471 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs